|
1
|
Hasegawa K, Takemura N, Yamashita T,
Watadani T, Kaibori M, Kubo S, Shimada M, Nagano H, Hatano E,
Aikata H, et al: Clinical practice guidelines for hepatocellular
carcinoma: The Japan society of hepatology 2021 version (5th
JSH-HCC guidelines). Hepatol Res. 53:383–390. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reig M, Forner A, Rimola J, Ferrer-Fàbrega
J, Burrel M, Garcia-Criado Á, Kelley RK, Galle PR, Mazzaferro V,
Salem R, et al: BCLC strategy for prognosis prediction and
treatment recommendation: The 2022 update. J Hepatol. 76:681–693.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bush DA, Smith JC, Slater JD, Volk ML,
Reeves ME, Cheng J, Grove R and de Vera ME: Randomized clinical
trial comparing proton beam radiation therapy with transarterial
chemoembolization for hepatocellular carcinoma: Results of an
interim analysis. Int J Radiat Oncol Biol Phys. 95:477–482. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim TH, Koh YH, Kim BH, Kim MJ, Lee JH,
Park B and Park JW: Proton beam radiotherapy vs. radiofrequency
ablation for recurrent hepatocellular carcinoma: A randomized phase
III trial. J Hepatol. 74:603–612. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hara K, Takeda A, Tsurugai Y, Saigusa Y,
Sanuki N, Eriguchi T, Maeda S, Tanaka K and Numata K: Radiotherapy
for hepatocellular carcinoma results in comparable survival to
radiofrequency ablation: A propensity score analysis. Hepatology.
69:2533–2545. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim N, Cheng J, Jung I, Liang J, Shih YL,
Huang WY, Kimura T, Lee VHF, Zeng ZC, Zhenggan R, et al:
Stereotactic body radiation therapy vs. radiofrequency ablation in
Asian patients with hepatocellular carcinoma. J Hepatol.
73:121–129. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shiba S, Shibuya K, Katoh H, Kaminuma T,
Miyazaki M, Kakizaki S, Shirabe K, Ohno T and Nakano T: A
comparison of carbon ion radiotherapy and transarterial
chemoembolization treatment outcomes for single hepatocellular
carcinoma: A propensity score matching study. Radiat Oncol.
14:1372019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brierley J, Gospodarowicz MK and Wittekind
Ch: TNM Classification of Malignant Tumours. 8th edition. John
Wiley & Sons, Inc.; Hoboken, NJ: pp. 106–112. 2017
|
|
9
|
Pugh RN, Murray-Lyon IM, Dawson JL,
Pietroni MC and Williams R: Transection of the oesophagus for
bleeding oesophageal varices. Br J Surg. 60:646–649. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Johnson PJ, Berhane S, Kagebayashi C,
Satomura S, Teng M, Reeves HL, O'Beirne J, Fox R, Skowronska A,
Palmer D, et al: Assessment of liver function in patients with
hepatocellular carcinoma: A new evidence-based approach-the ALBI
grade. J Clin Oncol. 33:550–558. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shibuya K, Ohno T, Katoh H, Okamoto M,
Shiba S, Koyama Y, Kakizaki S, Shirabe K and Nakano T: A
feasibility study of high dose hypofractionated carbon ion
radiation therapy using four fractions for localized hepatocellular
carcinoma measuring 3 cm or larger. Radiother Oncol. 132:230–235.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kasuya G, Kato H, Yasuda S, Tsuji H,
Yamada S, Haruyama Y, Kobashi G, Ebner DK, Okada NN, Makishima H,
et al: Progressive hypofractionated carbon-ion radiotherapy for
hepatocellular carcinoma: Combined analyses of 2 prospective
trials. Cancer. 123:3955–3965. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kato H, Tsujii H, Miyamoto T, Mizoe JE,
Kamada T, Tsuji H, Yamada S, Kandatsu S, Yoshikawa K, Obata T, et
al: Results of the first prospective study of carbon ion
radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int
J Radiat Oncol Biol Phys. 59:1468–1476. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Abe T, Saitoh J, Kobayashi D, Shibuya K,
Koyama Y, Shimada H, Shirai K, Ohno T and Nakano T: Dosimetric
comparison of carbon ion radiotherapy and stereotactic body
radiotherapy with photon beams for the treatment of hepatocellular
carcinoma. Radiat Oncol. 10:1872015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shiba S, Shibuya K, Kawashima M, Okano N,
Kaminuma T, Okamoto M, Kubota Y, Nakano T and Ohno T: Comparison of
dose distributions when using carbon ion radiotherapy versus
intensity modulated radiotherapy for hepatocellular carcinoma with
macroscopic vascular invasion: A retrospective analysis. Anticancer
Res. 40:459–464. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shiba S, Abe T, Shibuya K, Katoh H, Koyama
Y, Shimada H, Kakizaki S, Shirabe K, Kuwano H, Ohno T and Nakano T:
Carbon ion radiotherapy for 80 years or older patients with
hepatocellular carcinoma. BMC Cancer. 17:7212017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shiba S, Shibuya K, Katoh H, Koyama Y,
Okamoto M, Abe T, Ohno T and Nakano T: No deterioration in clinical
outcomes of carbon ion radiotherapy for sarcopenia patients with
hepatocellular carcinoma. Anticancer Res. 38:3579–3586. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang Y, Hidaka M, Takatsuki M, Soyama A,
Adachi T, Ono S, Kugiyama T, Hara T, Okada S, Yoshimoto T, et al:
Surgical findings and technical knacks to performing living donor
liver transplantation for hepatocellular carcinoma recurrence after
carbon ion radiotherapy. J Surg Case Rep. 2018:rjy2282018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kojiro M and Nakashima O: Histopathologic
evaluation of hepatocellular carcinoma with special reference to
small early stage tumors. Semin Liver Dis. 19:287–296. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maeda T, Takenaka K, Taguchi K, Kajiyama
K, Shirabe K, Shimada M, Tsuneyoshi M and Sugimachi K:
Clinicopathological characteristics of surgically resected minute
hepatocellular carcinomas. Hepatogastroenterology. 47:498–503.
2000.PubMed/NCBI
|
|
21
|
Nakashima Y, Nakashima O, Tanaka M, Okuda
K, Nakashima M and Kojiro M: Portal vein invasion and intrahepatic
micrometastasis in small hepatocellular carcinoma by gross type.
Hepatol Res. 26:142–147. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Okusaka T, Okada S, Ueno H, Ikeda M,
Shimada K, Yamamoto J, Kosuge T, Yamasaki S, Fukushima N and
Sakamoto M: Satellite lesions in patients with small hepatocellular
carcinoma with reference to clinicopathologic features. Cancer.
95:1931–1937. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kokudo T, Hasegawa K, Matsuyama Y,
Takayama T, Izumi N, Kadoya M, Kudo M, Ku Y, Sakamoto M, Nakashima
O, et al: Survival benefit of liver resection for hepatocellular
carcinoma associated with portal vein invasion. J Hepatol.
65:938–943. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ishihara S, Haga H, Yasuda M, Mizutani T,
Kawabata K, Shirato H and Nishioka T: Integrin beta1-dependent
invasive migration of irradiation-tolerant human lung
adenocarcinoma cells in 3D collagen matrix. Biochem Biophys Res
Commun. 396:651–655. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsutsumi K, Tsuda M, Yazawa N, Nakamura H,
Ishihara S, Haga H, Yasuda M, Yamazaki R, Shirato H, Kawaguchi H,
et al: Increased motility and invasiveness of tumor cells that
survived 10 Gy irradiation. Cell Struct Funct. 34:89–96. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nishioka T, Yasuda M, Tsutsumi K, Haga H
and Shirato H: Matrixmetalloproteinases: Up-regulated in subclones
that survived 10-Gy irradiation. Radiat Med. 25:430–431. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hokuto D, Nomi T and Yamato I: Colorectal
liver metastasis resected in a salvage operation for local
recurrence after proton beam radiotherapy. Jpn J Gastroenterol
Surg. 48:684–690. 2015. View Article : Google Scholar
|
|
28
|
Bruix J and Sherman M: American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen F, Matsuo Y, Yoshizawa A, Sato T,
Sakai H, Bando T, Okubo K, Shibuya K and Date H: Salvage lung
resection for non-small cell lung cancer after stereotactic body
radiotherapy in initially operable patients. J Thorac Oncol.
5:1999–2002. 2010. View Article : Google Scholar : PubMed/NCBI
|
